Company

NicOx

As of the edition of 20 October 2026, NicOx runs 1 drug; it is on route A at 2 targets and on route B at 0 targets.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Went quiet1
Total1

Where it needs a new molecule

Route A at 2 targets, route B at 0 targets.

Three of its 2 rows, by target and route
TargetRoute
PTGS1 Prostaglandin G/H synthase 1Route A
PTGS2 Prostaglandin G/H synthase 2Route A

All 2 rows on route A or B

In the product

2 company-target rows on route A or B; 0 are not shown here, and no score is.

Where its trials are

  • Bones, joints and muscles: 5 trials led
  • Heart and blood vessels: 2 trials led
  • Digestive system: 1 trials led